Triple Negative Breast Cancer 5-Year Survival Rate

The prognosis of triple-negative breast cancer is often poor with lower survival rates and a high risk of recurrence. Learn ways to improve outcomes.

Frontiers A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With de novo Distant Metastasis

Surviving Triple-Negative Breast Cancer: Hope, Treatment, and Recovery: 9780195387629: Medicine & Health Science Books @

JASN_News on X: Reliable prediction tools are needed to personalize treatment in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis. This study shows the updated score optimizes clinicopathologic prognostication for clinical

Dynamic nomogram: an example. A patient with HPV-related N2 disease at

Cancers, Free Full-Text

Kaplan–Meier disease-free survival by breast cancer subtypes. 5-year

Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics

Survival, treatment regimens and medical costs of women newly diagnosed with metastatic triple-negative breast cancer

Triple-negative breast cancer recurrence: Outlook and treatment

Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C - ScienceDirect